▶ 調査レポート

世界の新生児スクリーニング市場2021年-2031年:製品別(機器、アッセイキット)、検査別、エンドユーザー別

• 英文タイトル:Newborn Screening Market (Product: Instruments and Assay Kits; Test Type: Dry Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Disease [CCHD] Test, X-ray or CT Scan, Electrocardiogram [ECG] Test, and Others; and End User: Hospitals, Diagnostic Centers, Maternity & Specialty Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Transparency Market Researchが調査・発行した産業分析レポートです。世界の新生児スクリーニング市場2021年-2031年:製品別(機器、アッセイキット)、検査別、エンドユーザー別 / Newborn Screening Market (Product: Instruments and Assay Kits; Test Type: Dry Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Disease [CCHD] Test, X-ray or CT Scan, Electrocardiogram [ECG] Test, and Others; and End User: Hospitals, Diagnostic Centers, Maternity & Specialty Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 / MRC2106B010資料のイメージです。• レポートコード:MRC2106B010
• 出版社/出版日:Transparency Market Research / 2021年3月9日
• レポート形態:英文、PDF、185ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Site Licence¥1,301,660 (USD8,795)▷ お問い合わせ
  Enterprise Licence¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査レポートは、世界の新生児スクリーニング市場について調査し、序論、仮定/調査手法、エグゼクティブサマリー、市場概要、市場展望、製品別(機器、アッセイキット)分析、検査別分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを徹底分析したものです。
・序論
・仮定/調査手法
・エグゼクティブサマリー
・市場概要
・市場展望
・世界の新生児スクリーニング市場規模:製品別(機器、アッセイキット)
・世界の新生児スクリーニング市場規模:検査別
・世界の新生児スクリーニング市場規模:エンドユーザー別
・世界の新生児スクリーニング市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Newborn Screening Market – Scope of the Report

TMR’s report on the global newborn screening market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2021 to 2031. The report provides revenue of the global newborn screening market for the period 2017–2031, considering 2019 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global newborn screening market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the newborn screening market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global newborn screening market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global newborn screening market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global newborn screening market.

The report delves into the competition landscape of the global newborn screening market. Key players operating in the global newborn screening market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global newborn screening market profiled in this report.

Key Questions Answered in Newborn Screening Market Report

What is the sales/revenue generated by newborn screening across all regions during the forecast period?
What are the opportunities in the global newborn screening market?
What are major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which product segment is expected to generate the highest revenue globally in 2031? Which segment is projected to expand at the highest CAGR during the forecast period?
What is the market position of different companies operating in the global market?
Newborn Screening Market – Research Objectives and Research Approach

The comprehensive report on the global newborn screening market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global newborn screening market in terms of product, test type, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global newborn screening market.

レポート目次

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Global Newborn Screening Market Forecast
4.4. Global Newborn Screening Market Outlook
5. Market Outlook
5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.3. Overview of the Neonatal Research Funding/Grants
6. Global Newborn Screening Market Analysis, by Product
6.1. Introduction
6.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by Product
6.3. Global Newborn Screening Market Forecast, by Product
6.3.1. Instruments
6.3.1.1. Tabletop
6.3.1.2. Point-of-Care Testing
6.3.2. Assay Kits
6.4. Global Newborn Screening Market Analysis, by Product
7. Global Newborn Screening Market Analysis, by Test Type
7.1. Introduction
7.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
7.3. Global Newborn Screening Market Forecast, by Test Type
7.3.1. Dry Blood Spot Test
7.3.2. Hearing Screen Test
7.3.3. Critical Congenital Heart Disease (CCHD) Test
7.3.4. X-ray or CT Scan
7.3.5. Electrocardiogram (ECG) Test
7.3.6. Others
7.4. Global Newborn Screening Market Analysis, by Test Type
8. Global Newborn Screening Market Analysis, by End-user
8.1. Introduction
8.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
8.3. Global Newborn Screening Market Forecast, by End-user
8.3.1. Hospitals
8.3.2. Diagnostic Centers
8.3.3. Maternity & Specialty Clinics
8.3.4. Others
8.4. Global Newborn Screening Market Analysis, by End-user
9. Global Newborn Screening Market Analysis, by Region
9.1. Global Newborn Screening Market Scenario, by Region/Country
9.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by Region
9.3. Global Newborn Screening Market Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
10. North America Newborn Screening Market Analysis
10.1. North America Newborn Screening Market Overview
10.2. North America Newborn Screening Market Value Share and Attractiveness Analysis, by Country
10.3. North America Newborn Screening Market Forecast, by Country
10.3.1. U.S.
10.3.2. Canada
10.4. North America Newborn Screening Market Value Share and Attractiveness Analysis, by Product
10.5. North America Newborn Screening Market Forecast, by Product
10.5.1. Instruments
10.5.1.1. Tabletop
10.5.1.2. Point-of-Care Testing
10.5.2. Assay Kits
10.6. North America Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
10.7. North America Newborn Screening Market Forecast, by Test Type
10.7.1. Dry Blood Spot Test
10.7.2. Hearing Screen Test
10.7.3. Critical Congenital Heart Disease (CCHD) Test
10.7.4. X-ray or CT Scan
10.7.5. Electrocardiogram (ECG) Test
10.7.6. Others
10.8. North America Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
10.9. North America Newborn Screening Market Forecast, by End-user
10.9.1. Hospitals
10.9.2. Diagnostic Centers
10.9.3. Maternity & Specialty Clinics
10.9.4. Others
11. Europe Newborn Screening Market Analysis
11.1. Europe Newborn Screening Market Overview
11.2. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.3. Europe Newborn Screening Market Forecast, by Country/Sub-region
11.3.1. Germany
11.3.2. France
11.3.3. U.K.
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe
11.4. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by Product
11.5. Europe Newborn Screening Market Forecast, by Product
11.5.1. Instruments
11.5.1.1. Tabletop
11.5.1.2. Point-of-Care Testing
11.5.2. Assay Kits
11.6. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
11.7. Europe Newborn Screening Market Forecast, by Test Type
11.7.1. Dry Blood Spot Test
11.7.2. Hearing Screen Test
11.7.3. Critical Congenital Heart Disease (CCHD) Test
11.7.4. X-ray or CT Scan
11.7.5. Electrocardiogram (ECG) Test
11.7.6. Others
11.8. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
11.9. Europe Newborn Screening Market Forecast, by End-user
11.9.1. Hospitals
11.9.2. Diagnostic Centers
11.9.3. Maternity & Specialty Clinics
11.9.4. Others
12. Asia Pacific Newborn Screening Market Analysis
12.1. Asia Pacific Newborn Screening Market Overview
12.2. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Asia Pacific Newborn Screening Market Forecast, by Country/Sub-region
12.3.1. Japan
12.3.2. China
12.3.3. India
12.3.4. South Korea
12.3.5. Rest of Asia Pacific
12.4. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by Product
12.5. Asia Pacific Newborn Screening Market Forecast, by Product
12.5.1. Instruments
12.5.1.1. Tabletop
12.5.1.2. Point-of-Care Testing
12.5.2. Assay Kits
12.6. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
12.7. Asia Pacific Newborn Screening Market Forecast, by Test Type
12.7.1. Dry Blood Spot Test
12.7.2. Hearing Screen Test
12.7.3. Critical Congenital Heart Disease (CCHD) Test
12.7.4. X-ray or CT Scan
12.7.5. Electrocardiogram (ECG) Test
12.7.6. Others
12.8. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
12.9. Asia Pacific Newborn Screening Market Forecast, by End-user
12.9.1. Hospitals
12.9.2. Diagnostic Centers
12.9.3. Maternity & Specialty Clinics
12.9.4. Others
13. Latin America Newborn Screening Market Analysis
13.1. Latin America Newborn Screening Market Overview
13.2. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Latin America Newborn Screening Market Forecast, by Country/Sub-region
13.3.1. Brazil
13.3.2. Mexico
13.3.3. Rest of Latin America
13.4. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by Product
13.5. Latin America Newborn Screening Market Forecast, by Product
13.5.1. Instruments
13.5.1.1. Tabletop
13.5.1.2. Point-of-Care Testing
13.5.2. Assay Kits
13.6. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
13.7. Latin America Newborn Screening Market Forecast, by Test Type
13.7.1. Dry Blood Spot Test
13.7.2. Hearing Screen Test
13.7.3. Critical Congenital Heart Disease (CCHD) Test
13.7.4. X-ray or CT Scan
13.7.5. Electrocardiogram (ECG) Test
13.7.6. Others
13.8. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
13.9. Latin America Newborn Screening Market Forecast, by End-user
13.9.1. Hospitals
13.9.2. Diagnostic Centers
13.9.3. Maternity & Specialty Clinics
13.9.4. Others
14. Middle East & Africa Newborn Screening Market Analysis
14.1. Middle East & Africa Newborn Screening Market Overview
14.2. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.3. Middle East & Africa Newborn Screening Market Forecast, by Country/Sub-region
14.3.1. GCC Countries
14.3.2. South Africa
14.3.3. Rest of Middle East & Africa
14.4. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by Product
14.5. Middle East & Africa Newborn Screening Market Forecast, by Product
14.5.1. Instruments
14.5.2. Tabletop
14.5.3. Point-of-Care Testing
14.5.4. Assay Kits
14.6. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
14.7. Middle East & Africa Newborn Screening Market Forecast, by Test Type
14.7.1. Dry Blood Spot Test
14.7.2. Hearing Screen Test
14.7.3. Critical Congenital Heart Disease (CCHD) Test
14.7.4. X-ray or CT Scan
14.7.5. Electrocardiogram (ECG) Test
14.7.6. Others
14.8. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
14.9. Middle East & Africa Newborn Screening Market Forecast, by End-user
14.9.1. Hospitals
14.9.2. Diagnostic Centers
14.9.3. Maternity & Specialty Clinics
14.9.4. Others
15. Competition Landscape
15.1. Competition Matrix
15.2. Company Share Analysis, 2019
15.3. Company Profiles
15.3.1. PerkinElmer, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Trivitron Healthcare
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. Natus Medical Incorporated
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Medtronic plc
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Thermo Fisher Scientific, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Bio-Rad Laboratories, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. GE Healthcare (General Electric Company)
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. ZenTech S.A.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. MP BIOMEDICALS
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. Baebies, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview
15.3.11. Masimo
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Financial Overview
15.3.11.3. Product Portfolio
15.3.11.4. SWOT Analysis
15.3.11.5. Strategic Overview